Drug giant Merck has created a medication that "turns off" production of the amyloid plaques associated with Alzheimer's Disease. It does this by reducing the presence of two precursor chemicals in the blood, according to an article in The Guardian (U.K.).
Yet to be determined is if it also stops degradation of mental function. This should be known in another year or so. Great news, if it pans out. Hat tip to Instapundit for the link.
